NCT01738139 2024-03-21Ipilimumab and Imatinib Mesylate in Advanced CancerM.D. Anderson Cancer CenterPhase 1 Completed68 enrolled
NCT01643278 2017-01-10Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are MetastaticNational Cancer Institute (NCI)Phase 1 Completed29 enrolled